RGEN
Repligen Corp
Price:  
122.31 
USD
Volume:  
693,601.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN Relative Valuation

-72.2%
Upside

As of 2026-06-07, the Relative Valuation of Repligen Corp (RGEN) is 34.05 USD. This relative valuation is based on P/E multiples. With the latest stock price at 122.31 USD, the upside of Repligen Corp based on Relative Valuation is -72.2%.

The range of the Relative Valuation is 25.62 - 52.39 USD.

Range Selected
Trailing P/E multiples 28.1x - 57.5x 37.8x
Forward P/E multiples 24.4x - 35.0x 25.3x
Fair Price 25.62 - 52.39 34.05
Upside -79.1% - -57.2% -72.2%
122.31 USD
Stock Price
34.05 USD
Fair Price

RGEN Relative Valuation - Historical P/E Data

Date P/E
2026-06-05 134.24
2026-06-04 138.89
2026-06-03 133.60
2026-06-02 132.94
2026-06-01 135.11
2026-05-29 136.04
2026-05-28 134.70
2026-05-27 124.21
2026-05-26 126.43
2026-05-22 126.28
2026-05-21 124.43
2026-05-20 122.64
2026-05-19 119.10
2026-05-18 114.36
2026-05-15 112.90
2026-05-14 113.46
2026-05-13 117.47
2026-05-12 124.68
2026-05-11 127.22
2026-05-08 135.50
2026-05-07 138.76
2026-05-06 138.03
2026-05-05 137.86
2026-05-04 129.74
2026-05-01 128.63
2026-04-30 129.85
2026-04-29 124.14
2026-04-28 128.88
2026-04-27 129.83
2026-04-24 129.07
2026-04-23 125.18
2026-04-22 136.53
2026-04-21 145.64
2026-04-20 144.86
2026-04-17 144.01
2026-04-16 139.49
2026-04-15 144.80
2026-04-14 143.81
2026-04-13 134.55
2026-04-10 131.81
2026-04-09 131.46
2026-04-08 131.45
2026-04-07 126.53
2026-04-06 128.36
2026-04-02 129.27
2026-04-01 129.86
2026-03-31 129.31
2026-03-30 122.36
2026-03-27 120.86
2026-03-26 125.58